Cargando…
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection
Autores principales: | Lambertini, Alessandro, Hartrampf, Philipp E., Higuchi, Takahiro, Serfling, Sebastian E., Meybohm, Patrick, Schirbel, Andreas, Buck, Andreas K., Werner, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371958/ https://www.ncbi.nlm.nih.gov/pubmed/35953728 http://dx.doi.org/10.1007/s00259-022-05932-4 |
Ejemplares similares
-
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera
por: Hartrampf, Philipp E., et al.
Publicado: (2020) -
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
por: Werner, Rudolf A., et al.
Publicado: (2022) -
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [(68)Ga]Ga-PentixaFor PET/CT
por: Serfling, Sebastian E., et al.
Publicado: (2022) -
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer
por: Serfling, Sebastian E., et al.
Publicado: (2023) -
CXCR4-targeted theranostics in oncology
por: Buck, Andreas K., et al.
Publicado: (2022)